chevron_leftBack
As of 5 June 2026, Samyang Biopharm Corp. has a market cap of $376.83M USD, ranking #17096 globally and #533 in South Korea.
It ranks #1554 in the Healthcare sector, and #327 in the Medical Devices industry.
Key Stats
Market Cap
$376.83MUSD
579.25B KRW
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Kyeong-Jin Kim
open_in_new
Founded
2011
Website
samyangbiopharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.1% | -1.3% | -46% | -27% | -13% | 134% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
0120G0
ISIN: KR70120G0001
Shares Out.:
Shares Outstanding:
7.43M1
Shares Float:
3.984M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
75,500 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Samyang Biopharm Corp.
Samyang Biopharm Corporation offers pharmaceutical and biotech products. The company was founded in 2011 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.44B
548%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.21B
222%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.18B
212%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.13B
200%
1.74T KRW
|
-
|
|
KRX: 096530
|
$751.49M
99%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$526.7M
40%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
46K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
43K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
42K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
33K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
32K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
27K%
|
22.2
|
chevron_leftBack